About: New antithrombotic agents

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: New antithrombotic agents Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 April 1999

Attributes	Values
rdf:type	Item
description	наукова стаття, опублікована у квітні 1999 (uk) im April 1999 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'abril de 1999 (ast) scientific article published on 01 April 1999 (en)
publication date	wds:Q77397128-E8A0775B-F7FB-4AE3-9CD8-32F7B4214C0C
publication date	1999-04-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q77397128-B6163408-210B-47FB-9B69-2F525BDB4345
language of work or name	English
cites work	wds:Q77397128-01B5C32D-4C4E-427B-8C7E-EF2581AA7378 wds:Q77397128-0C8D63BA-9A21-4834-B6DB-147218087A9B wds:Q77397128-0F7BD8C5-0EA1-4AA8-81FB-A1BF39E0F44C wds:Q77397128-135D485D-B956-4BD1-AAE8-6D9486B325F9 wds:Q77397128-1D125AE1-96AF-423F-946F-EB0872345648 wds:Q77397128-2E68E4CE-7317-4F5E-BDFD-81DF95AB3BE8 wds:Q77397128-37EA3348-39EE-4BB7-BBA9-58AA9DBFEDED wds:Q77397128-38B39C63-01CC-4AE4-BE31-C1514276DF4C wds:Q77397128-3C2A4DA3-F61E-4A8F-883E-E0B0771BAF7E wds:Q77397128-50F3B87F-E71F-4E17-B2A8-D3CD6B13CA41 wds:Q77397128-5C362202-1DE7-4B54-9949-D52364C9D4A8 wds:Q77397128-6148583E-142F-4209-B672-20288D6E9F8E wds:Q77397128-64E9B597-A127-4949-AA86-8DF6CEDE0D5A wds:Q77397128-67D1D038-AD2D-456C-BA46-B5DE0E11BA75 wds:Q77397128-6B987131-C631-4EE3-B16E-A84E95DE934C wds:Q77397128-6CD37812-5495-4EDA-9DD5-C2FDE290B1BA wds:Q77397128-6DF6D428-6843-4212-8382-C112B22DE008 wds:Q77397128-75B22C21-88D5-47F0-980F-8454C9996630 wds:Q77397128-7EBCE3AD-7C48-4A8B-A99C-9C5BB5FED524 wds:Q77397128-8221A1E8-D01C-4966-81CD-DB567CD435A7 wds:Q77397128-824C1893-EEE7-495D-9D57-368F9D6B09AE wds:Q77397128-8AF75F5B-80EC-4642-B870-D415C20AA5BA wds:Q77397128-91276695-8620-4C67-BAD0-DB53281B1465 wds:Q77397128-99151D3C-73CD-4677-AA47-7D868C88FF5D wds:Q77397128-A1CD6B1B-A6E2-4C19-AE2D-8D02B1EB02D2 wds:Q77397128-A75EB1C8-5D69-4A49-B746-B506647A6DFD wds:Q77397128-AF134F5E-CEF0-4C5A-B785-5117DB9E50EF wds:Q77397128-AF6949B9-6952-441C-8AAC-283638B920A0 wds:Q77397128-B07EBE5C-5FC1-47A4-A4DE-CE3C16054126 wds:Q77397128-B4280197-F7C7-432C-9504-AF08399C9C94 wds:Q77397128-BE5621FD-4143-4B91-9C61-31D4A9B77D0E wds:Q77397128-C0156F0B-1839-4BF3-9191-47B189FACA86 wds:Q77397128-CB698356-853E-4F89-A737-1FBA2D369BED wds:Q77397128-CD9298FF-1189-45EB-9818-9598A2BB8AAF wds:Q77397128-E27669B0-0529-4977-A88F-B27CA4D9FDF5 wds:Q77397128-EC9C64BF-8D08-49DE-B329-F9213B6ED7C0 wds:Q77397128-F4499E2B-EDD2-4E67-8F32-D8B62D923AF7
cites work	A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement. Heparin Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty Aspirin as an antiplatelet drug Platelet GPIIb-IIIa blockers Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group Oral anticoagulant drugs Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin Kinetics of the inhibition of thrombin by hirudin. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization Anticoagulant repertoire of the hookworm Ancylostoma caninum Low-molecular-weight heparins A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. The PARAGON Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events i Heparinless cardiopulmonary bypass with active-site blocked factor IXa: a preliminary study on the dog. Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty. Molecular and cellular biology of blood coagulation A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee Importance of factor Xa in determining the procoagulant activity of whole-blood clots An update on clinical and basic aspects of the protein C anticoagulant pathway. Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial Six-month angiographic and clinical follow-up of patients prospectively randomized to receive either tirofiban or placebo during angioplasty in the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis. Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial A low molecular weight, selective thrombin inhibitor, inogatran, vs heparin, in unstable coronary artery disease in 1209 patients. A double-blind, randomized, dose-finding study. Thrombin inhibition in Myocardial Ischaemia (TRIM) study group Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators Antiplatelet rather than anticoagulant therapy with coronary stenting Treatment of homozygous protein C deficiency with subcutaneous protein C concentrate
author name string	wds:Q77397128-4F9B91FE-ACB8-496B-89BF-8F2B7A349CA4 wds:Q77397128-F87C4567-8106-417F-B397-FC4E6ED2C025
author name string	J Hirsh J I Weitz
rdfs:label	New antithrombotic agents (en)
skos:prefLabel	New antithrombotic agents (en)
name	New antithrombotic agents (en)
title	wds:Q77397128-4A507A1E-F226-4F8C-83F7-6065EF9F5444
title	New antithrombotic agents (en)
page(s)	wds:Q77397128-3340CB0B-F4A8-4DE3-9542-1936AE93AD3A
page(s)	1431-1436
instance of	wds:Q77397128-5b14c0d9-7821-49e0-b960-f7bc6733d9d4 wds:Q77397128-D818B967-5821-4C80-991D-72FAFA0FB71C
instance of	review article scholarly article
PubMed ID	wds:Q77397128-FD7BD779-23D0-43C8-8D93-0831680B730F
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10227240

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software